Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company headquartered in Stafford, Texas, dedicated to pioneering immunotherapy approaches for cancer treatment, with a strong emphasis on HER2/neu-expressing tumors, including those associated with breast cancer. Its lead investigational candidate, GP2, aims to enhance the immune response against malignant cells, addressing significant unmet medical needs in oncology. With a focused pipeline of innovative therapies and a strategic vision for advancing cancer care, Greenwich LifeSciences is well-positioned to drive transformative developments in patient outcomes within the rapidly evolving landscape of cancer therapeutics. Show more

Location: BUILDING 14, STAFFORD, TX, UNITED STATES, 77477, Stafford, TX, 77477, USA | Website: https://greenwichlifesciences.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE